I’m pleased to share that Susan Doig, Trilogy’s Chief Clinical Officer, has been appointed by Trilogy’s Board of Directors to serve as Trilogy’s Interim President and CEO starting October 4th. Susan has been a key part of Trilogy for 17 years and has served as Chief Clinical Officer for more than ten. She has been instrumental in charting Trilogy’s course during her tenure and has played an integral role in focusing Trilogy’s mission, vision, and day-to-day operations.

Susan is taking the reins from Samantha Handley, who has moved on to a new opportunity after 15 years at Trilogy. We are extremely grateful to Samantha for her steadfast service to the organization and we wish her all the best in her new endeavor. Trilogy’s Board of Directors will continue to work closely with Susan and the Strategy Team to ensure a smooth transition during this period.

As a partner of Trilogy’s work, we thank you for your ongoing support of our mission to provide comprehensive integrated care that enables those in mental health recovery to live meaningful and independent lives. I look forward to providing updates on Trilogy’s search for a permanent leader in future communications.

Sincerely,  

Aimee Feuser, Trilogy Board Chair